STAR*D - Wikipedia
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) was a collaborative study on the treatment of depression, funded by the National Institute of Mental Health. Its main focus was on the treatment of depression in patients where the …
Sequenced Treatment Alternatives to Relieve Depression (STAR*D…
2008年2月25日 · The NIMH-funded Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study was conducted to determine the effectiveness of different treatments for people with major depression who have not responded to initial treatment with an antidepressant.
What Did STAR*D Teach Us? Results From a Large-Scale, Practical ...
2009年11月1日 · STAR*D is the largest prospective clinical trial of major depressive disorder ever conducted. It was a multicenter, nationwide association of 14 university-based regional centers, which oversaw a total of 23 participating psychiatric clinics and 18 primary care clinics.
Relieve Depression (STAR*D) study, the largest prospective clinical trial of treatment of major depressive disorder ever conducted. It was funded by the National Institutes of Health and directed by A. John Rush, MD. WHAT WERE THE AIMS OF STAR*D? Depression, a common and debilitating condi-tion, affects approximately one in eight people
Sequenced treatment alternatives to relieve depression (STAR*D ... - PubMed
STAR*D is a multisite, prospective, randomized, multistep clinical trial of outpatients with nonpsychotic major depressive disorder. The study compares various treatment options for those who do not attain a satisfactory response with citalopram, a selective serotonin reuptake inhibitor antidepressa …
Questions and Answers about the NIMH Sequenced Treatment …
STAR*D aimed for the first time to provide solid scientific evidence regarding which next treatment steps are best for treatment-resistant depression. The results should produce clinical, administrative and economic benefits.
Questions and Answers about the NIMH Sequenced Treatment …
The overall goal of the STAR*D trial was to assess the effectiveness of depression treatments in patients diagnosed with major depressive disorder, in both primary and specialty care settings. It is the largest and longest study ever conducted to evaluate depression treatment. Read more about STAR*D.
The STAR*D study: Treating depression in the real world
2008年1月1日 · The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study evaluated feasible treatment strategies to improve clinical outcomes for real-world patients with treatment-resistant depression.
Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results ...
The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study provided the ... Several lines of evidence support an important genetic contribution to the wide individual variation in therapeutic response to antidepressant medications.
STAR∗D aimed to determine which of several treatments are the most effective “next-step” treatments for patients whose symptoms do not re-mit or who cannot tolerate the initial treatment and, if needed, ensuing treatments. This article provides an overview of the design, methods, and results of STAR∗D, with attention to